Fluid Biomarkers in Hereditary Spastic Paraplegia: A Narrative Review and Integrative Framework for Complex Neurodegenerative Mechanisms
Genes · 13.10.2025 · 16 (10) · 1189
DOI: 10.3390/genes16101189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 13.10.2025. Verfasst von Lorenzo Cipriano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine, IRCCS Fondazione Stella Maris, 56128 Pisa, Italy. Hauptthemen laut MEDLINE: Biomarkers, Spastic Paraplegia, Hereditary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health, Ricerca Corrente 2024.
Abstract (Originalsprache)
Background
Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative disorders marked by progressive corticospinal tract dysfunction and wide phenotypic variability. Their genetic heterogeneity has so far limited the identification of biomarkers that are broadly applicable across different subtypes.
Objective
We aim to define a balanced review on the use of biomarkers in HSP.
Methods
This review focuses on fluid biomarkers already available in clinical or research settings—primarily validated in other neurodegenerative diseases—and assesses their potential translation to the HSP context. Biomarkers such as neurofilament light chain, brain-derived tau, glial fibrillary acidic protein, and soluble TREM2 reflect key converging mechanisms of neurodegeneration, including axonal damage, neuronal loss, and glial activation. These shared downstream pathways represent promising targets for disease monitoring in HSP, independently of the underlying genetic mutation.
Results
An integrative framework of fluid biomarkers could assist in defining disease progression and stratify patients in both clinical and research settings. Moreover, recent advances in ultrasensitive assays and remote sampling technologies, such as dried blood spot collection, offer concrete opportunities for minimally invasive, longitudinal monitoring. When combined with harmonized multicenter protocols and digital infrastructure, these tools could support scalable and patient-centered models of care.
Conclusions
The integration of already available biomarkers into the HSP field may accelerate clinical translation and offer a feasible strategy to overcome the challenges posed by genetic and clinical heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Medicine, IRCCS Fondazione Stella Maris, 56128 Pisa, Italy.
- Department of Molecular Medicine and Medical Biotechnology, University Federico II, 80131 Naples, Italy.
ORCID-Profile: Lorenzo Cipriano
Förderung
- Ministero della Salute
- Italian Ministry of Health
- Ricerca Corrente 2024
- Telethon
Zitieren
APA
Cipriano, L., Setola, N., Barghigiani, M., & Santorelli, F. M. (2025). Fluid Biomarkers in Hereditary Spastic Paraplegia: A Narrative Review and Integrative Framework for Complex Neurodegenerative Mechanisms. Genes, 16(10), 1189. https://doi.org/10.3390/genes16101189
Vancouver
Cipriano L, Setola N, Barghigiani M, Santorelli FM. Fluid Biomarkers in Hereditary Spastic Paraplegia: A Narrative Review and Integrative Framework for Complex Neurodegenerative Mechanisms. Genes. 2025;16(10):1189. doi:10.3390/genes16101189
BibTeX
@article{Cipriano2025,
author = {Cipriano, Lorenzo and Setola, Nunzio and Barghigiani, Melissa and Santorelli, Filippo Maria},
title = {Fluid Biomarkers in Hereditary Spastic Paraplegia: A Narrative Review and Integrative Framework for Complex Neurodegenerative Mechanisms},
journal = {Genes},
year = {2025},
volume = {16},
number = {10},
pages = {1189},
doi = {10.3390/genes16101189}
}
EUVIMED